medtronic

Medtronic Upgraded to “Buy” at Goldman Sachs (MDT)

Medical device maker Medtronic, Inc. ( MDT ) on Friday caught a big upgrade from analysts at Goldman Sachs. The firm said it boosted its rating on MST from “Neutral” to “Buy” while raising its price target from $37 to $45. That new target implies an 18% upside from the stock’s Thursday closing price of $37.99. Goldman cited higher earnings forecasts and growing valuations for MDT’s peers for the upgrade. The analyst also noted that new management could drive upside with more aggressive corporate action, and some new cardiac rhythm products could also boost earnings. Medtronic shares rose 71 cents, or +1.9%, in premarket trading Friday. The Bottom Line Shares of Medtronic ( MDT ) have a 2.37% dividend yield, based on last night’s closing stock price of $37.99. The stock has technical support in the $34 price area. If the shares can firm up, we see overhead resistance around the $39-$41 price levels. Medtronic, Inc. ( MDT ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

MDT, Ardian Target Hypertension – Analyst Blog

Filed in BP, Gold Prices, medtronic, o, silver, Uncategorized by on January 14, 2011 0 Comments

Medtronic has completed the acquisition of privately-held Ardian for an upfront payment of $800 million

Continue Reading »

Top Picks 2011: Medtronic (MDT)

Filed in Bank Gold, medtronic, o by on January 4, 2011 0 Comments
Top Picks 2011: Medtronic (MDT)

Filed under: Newsletters , Stocks to Buy , Best Stocks for 2011 This post is one in a series in which more than 60 newsletter advisors share their Top Stock Picks for 2011 . This special report is courtesy of TheStockAdvisors.com . “For over 50 years, Medtronic ( MDT ) has been the premier medical device manufacturer in the marketplace,” notes Jim Stack . The money manager and editor of InvesTech Market Analyst explains, “With the invention of the battery-powered pacemaker in the mid 1950s, Medtronic began a long string of technological innovations. Continue reading Top Picks 2011: Medtronic (MDT) Top Picks 2011: Medtronic (MDT) originally appeared on BloggingStocks on Tue, 04 Jan 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Continue Reading »

Top Picks 2011: Favorite Stocks from 60+ Advisors

Filed in Apple, Bank Gold, Cisco, citigroup, medtronic, o by on December 27, 2010 0 Comments
Top Picks 2011: Favorite Stocks from 60+ Advisors

Filed under: Stocks to Buy , Stock Picks , Best Stocks for 2011 Looking for a shopping list of new stock ideas for 2011? Each year for 28 years, TheStockAdvisors.com has turned to the nation’s most respected and well-known newsletter advisors and asked them for their favorite investment ideas for the coming 12 months. With 65 advisors participating in this year’s survey, there’s something for every type of investor, from high-quality blue chips to speculative home runs. Continue reading Top Picks 2011: Favorite Stocks from 60+ Advisors Top Picks 2011: Favorite Stocks from 60+ Advisors originally appeared on BloggingStocks on Mon, 27 Dec 2010 09:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Continue Reading »

Trade The News Weekly Market Update

– Volatile trading has been the rule during the Thanksgiving-shortened week. In weekend negotiations with the ECB and the IMF, Dublin dropped its initial reluctance to a bailout and agreed to accept funds. Having evidently learned a lesson from the painfully drawn-out Greek crisis earlier in the year, European partners are rushing to finalize details of a rescue package, which will apparently amount to €85-100B, and will include funding from the ECB, the IMF and the UK. Meanwhile, contagion from the sell-off in Irish bonds has already driven risk spreads in Portugal and Spain to record levels, as S&P exerted additional pressure by cutting Ireland’s sovereign rating two notches. On Tuesday North Korea shelled a South Korean island in one of the most dramatic attacks on the nation since the end of the Korean War. The attack sent US and European equity indices tumbling and completely sidelined the relatively strong second reading of US Q3 GDP. Key economic data in the US was also in play this week. After growing in September, existing and new home sales returned to declines in October; sky-high inventories helped push median new home prices to lows last seen in 2003, raising concerns about a double dip in housing prices. The October durables data was also cause for concern, as the nondefense capital goods figure (ex aircraft) was down 4.5%, missing nearly all estimates, though it was cushioned by an upward revision in the prior month. Hope was seen in the weekly initial jobless claims, which fell to their lowest level since July 2008, possibly portending sunnier results in the November payrolls report next week. For the week the DJIA fell 1%, the S&P500 dipped 0.9%, and the Nasdaq gained 0.7%. – It was a big week for private equity deals. An investment group struck a deal to buy software developer Novell for $6.10/share in cash, in a deal valued at $2.2B. The acquiring firm Attachmate, a provider of technology services, is owned by an investment group led by Francisco Partners, Golden Gate Capital and Thomas Bravo. Takeover chatter starting last week materialized in a private equity deal for Del Monte Foods, as a group led by KKR announced it would buy the foods company for $19.00/share. Clothier J. Crew confirmed it would be acquired by TPG and Leonard Green for $43.50/share. Blackstone lost its $602M bid to buy power producer Dynegy after failing to win shareholder support, likely forcing the company to find another buyer, sell assets or restructure. Blackstone met strong resistance from Dynegy’s two largest shareholders, Carl Icahn and hedge fund Seneca Capital. Elsewhere, German fertilizer giant K+S said it would acquire Canada’s Potash…

Continue Reading »

Goldman (NYSE:GS) Lowers EPS Estimates on Medtronic (NYSE:MDT)

Goldman Sachs (NYSE:GS) cut its earnings estimates on Medtronic (NYSE:MDT) while maintaining a “Neutral” rating on the company. Earnings were lowered in 2011 from $3.45 to $3.40, in 2012 from $3.67 to $3.60 and for 2013 from $3.97 to $3.45. Goldman said shrinking gross markets, lower sales guidance and interest income were the factors they considered in their decision. A price target of $36

Continue Reading »

Goldman (NYSE:GS), JPMorgan (NYSE:JPM) Maintain Neutral on Medtronic (NYSE:MDT)

Goldman Sachs (NYSE:GS) and JPMorgan (NYSE:JPM) both reiterated their “Neutral” rating on Medtronic (NYSE:MDT), citing little in the way of catalysts to drive the company forward, even though they may have a decent second quarter. Goldman said, “We maintain our Neutral rating despite expected upside in F2Q, as we do not see the drivers of strength (fluctuations in inventory levels) as an

Continue Reading »